Response plan to control and manage the threat of multidrug-resistant gonorrhoea in Europe
This response plan is designed to prevent the spread of multidrug-resistant Neisseria gonorrhoeae (MDR NG) in the EU/EEA in the context of the possible emergence of untreatable gonorrhoea
Report of the joint ECDC and WHO review of the national tuberculosis programme in Bulgaria
This report outlines the results of the joint ECDC and WHO review of the Bulgarian National Tuberculosis Control Programme.
Tuberculosis in Europe: from passive control to active elimination – high- and low-incidence countries
This four-page evidence brief provides an overview of tuberculosis control and elimination efforts in the EU/EEA, with a particular focus on the epidemiological differences between high- and low-incidence countries.
HIV and hepatitis B and C in Latvia
At the request of the Ministry of Health in Riga, a team of experts from ECDC and the European Monitoring Centre for Drugs and Drug Addiction paid a technical visit to Latvia on 2–4 September 2014.
Interim guidance for healthcare providers and Zika virus laboratory diagnosis
This document aims to present an algorithm for deciding whom to test and provide guidance on the laboratory tests for Zika virus infection diagnosis in order to support clinical diagnostic and case reporting through surveillance among EU Member States.
Guide to public health measures to reduce the impact of influenza pandemics in Europe – ‘The ECDC Menu’
This document presents a menu of possible public measures to be taken during influenza pandemics, giving public health and scientific information on what is known or can be said about their likely effectiveness, costs (direct and indirect), acceptability, public expectations and other more practical considerations. The ‘ECDC Menu’ aims to help EU Member States and institutions, individually or collectively, decide which measures they will apply.
Interim technical guidance on public health use of influenza antivirals during influenza pandemics
Antiviral drugs are an important addition to the public health arsenal against influenza. This interim guidance discusses the options for their effective use, especially during a pandemic.
Interim technical guidance on use of specific pandemic influenza vaccines during the H1N1 2009 pandemic
This interim guidance outlines the possible strategies that countries may wish to adopt in the deployment of a pandemic-specific vaccine, considering the two objectives of vaccination: protecting those at greatest risk of severe disease and maintaining essential services.
Technical guidance on mitigation and delaying (or ‘containment’)strategies as the new influenza A(H1N1) virus comes into Europe
As epidemics of the new influenza A(H1N1) virus are extending globally, some European countries are considering how robustly to undertake case-finding among the first cases and whether to pursue and treat contacts.
Social media strategy development – A guide to using social media for public health communication
This guide provides public health organisations and practitioners with a practical approach to strengthening the integration of social media into their overall communication activities.